Big Pharma, big lawsuits

November 22, 2017 Julie Miller

Brian Albright

The claimants in most of the pharma lawsuits want to see an end to what they characterize as aggressive and misleading opioid marketing as well as help in shouldering the enormous cost to states, counties and cities now dealing with overdose deaths.

Previous Article
How to counteract media bias against treatment centers

Julie Miller, Editor in ChiefMainstream media tends to be biased against providers, painting a grim picture...

Next Article
Annual cost of opioid crisis as high as $504 billion

Julie Miller, Editor in ChiefTwo recent research studies have placed dollar amounts on the staggering costs...

×

Have Behavioral Health Business updates sent to your inbox today!

First Name
Last Name
Thank you!
Error - something went wrong!